Treatment of catheter-induced thrombotic superior vena cava syndrome: a single institution's experience
| Autor: | Manuel Morales, Javier Dorta, Mercedes Trujillo, Valentí Comas |
|---|---|
| Rok vydání: | 2000 |
| Předmět: |
Adult
Male medicine.medical_specialty Superior Vena Cava Syndrome medicine.medical_treatment Catheters Indwelling Fibrinolytic Agents Superior vena cava Fibrinolysis medicine Humans Streptokinase Aged Urokinase Catheter insertion Superior vena cava syndrome business.industry Middle Aged medicine.disease Thrombosis Urokinase-Type Plasminogen Activator Surgery Catheter Treatment Outcome Oncology Female medicine.symptom business Central venous catheter medicine.drug |
| Zdroj: | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 8(4) |
| ISSN: | 0941-4355 |
| Popis: | Thrombosis is the most frequent benign etiology of superior vena cava syndrome among cancer patients who have a long-term central venous catheter. In this paper, six cases of thrombotic superior vena cava syndrome are discussed. There were four women and two men. One patient was treated with streptokinase and five with urokinase. The mean age was 46 years (range 22–69), and the mean time for thrombosis development after catheter insertion was 125 days (range: 53–211 days). The mean time for resolution of thrombosis was 7 days (range 2–11) in five patients. One patient had no response to fibrinolysis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink